Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
The Joint Corp
JYNT | US
8.70
USD-0.05
-0.57%
JYNT | US
About The Joint Corp
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
06/03/2026
Close
8.70
Open
8.58
High
8.81
Low
8.45
The Joint Corp. develops owns operates supports and manages chiropractic clinics. The company operates in two segments Corporate Clinics and Franchise Operations. It operates through direct ownership management arrangements franchising and regional developers. As of March 1 2022 the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale Arizona.
View LessJYNT | US
Risk
38.9
Sharpe
-0.62
Luna's Score
37/100
Recommendation
Sell
Luna says (JYNT | US)
What's Working
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
34.1%1 month
38.9%3 months
38.3%6 months
36.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
19.01
Price to book
7.38
Debt to equity
0.61
Debt to assets
0.17
Ent. to EBITDA
21.69
Ent. to rev.
1.40
PEG
-0.70
Other Fundamentals
EBITDA
7.73M
MarketCap
130.47M
MarketCap(USD)
130.47M
Div. yield
-
Op. margin
-6.82
Erngs. growth
-62.40
Rev. growth
3.30
Ret. on equity
-49.10
Short ratio
7.54
Short perc.
4.46
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.34
Range1M
2.13
Range3M
2.58
Volumes: Market Activity
Rel. volume
2.00
Price X volume
952.80K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.69 | 13.85 | Expensive |
| Ent. to Revenue | 1.40 | 1.73 | Par |
| PE Ratio | - | 22.94 | - |
| Price to Book | 7.38 | 14.91 | Cheaper |
| Dividend Yield | - | 1.25 | - |
| Std. Deviation (3M) | 38.31 | 51.88 | Lower Risk |
| Debt to Equity | 0.61 | 5.15 | Cheaper |
| Debt to Assets | 0.17 | 0.46 | Cheaper |
| Market Cap | 130.47M | 6.67B | Emerging |
